BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 25437040)

  • 1. Animal models of varicella zoster virus infection.
    Haberthur K; Messaoudi I
    Pathogens; 2013 May; 2(2):364-82. PubMed ID: 25437040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abortive intrabronchial infection of rhesus macaques with varicella-zoster virus provides partial protection against simian varicella virus challenge.
    Meyer C; Engelmann F; Arnold N; Krah DL; ter Meulen J; Haberthur K; Dewane J; Messaoudi I
    J Virol; 2015 Feb; 89(3):1781-93. PubMed ID: 25410871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4 T cell immunity is critical for the control of simian varicella virus infection in a nonhuman primate model of VZV infection.
    Haberthur K; Engelmann F; Park B; Barron A; Legasse A; Dewane J; Fischer M; Kerns A; Brown M; Messaoudi I
    PLoS Pathog; 2011 Nov; 7(11):e1002367. PubMed ID: 22102814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of varicella (VZV) vaccination: an update for the clinician.
    Wang L; Zhu L; Zhu H
    Ther Adv Vaccines; 2016 Jan; 4(1-2):20-31. PubMed ID: 27551429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varicella Virus-Host Interactions During Latency and Reactivation: Lessons From Simian Varicella Virus.
    Sorel O; Messaoudi I
    Front Microbiol; 2018; 9():3170. PubMed ID: 30619226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ORF61 Protein Encoded by Simian Varicella Virus and Varicella-Zoster Virus Inhibits NF-κB Signaling by Interfering with IκBα Degradation.
    Whitmer T; Malouli D; Uebelhoer LS; DeFilippis VR; Früh K; Verweij MC
    J Virol; 2015 Sep; 89(17):8687-700. PubMed ID: 26085158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into the pathogenesis of varicella viruses.
    Sorel O; Messaoudi I
    Curr Clin Microbiol Rep; 2019 Sep; 6(3):156-165. PubMed ID: 32999816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrabronchial infection of rhesus macaques with simian varicella virus results in a robust immune response in the lungs.
    Haberthur K; Meyer C; Arnold N; Engelmann F; Jeske DR; Messaoudi I
    J Virol; 2014 Nov; 88(21):12777-92. PubMed ID: 25142604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the treatment of varicella-zoster virus infections.
    Andrei G; Snoeck R
    Adv Pharmacol; 2013; 67():107-68. PubMed ID: 23886000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute Simian Varicella Virus Infection Causes Robust and Sustained Changes in Gene Expression in the Sensory Ganglia.
    Arnold N; Girke T; Sureshchandra S; Messaoudi I
    J Virol; 2016 Dec; 90(23):10823-10843. PubMed ID: 27681124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination of immunocompetent elderly subjects with a live attenuated Oka strain of varicella zoster virus: a randomized, controlled, dose-response trial.
    Trannoy E; Berger R; Holländer G; Bailleux F; Heimendinger P; Vuillier D; Creusvaux H
    Vaccine; 2000 Feb; 18(16):1700-6. PubMed ID: 10689152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances and Perspectives in the Management of Varicella-Zoster Virus Infections.
    Andrei G; Snoeck R
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33672709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivation of Simian Varicella Virus in Rhesus Macaques after CD4 T Cell Depletion.
    Traina-Dorge V; Palmer BE; Coleman C; Hunter M; Frieman A; Gilmore A; Altrock K; Doyle-Meyers L; Nagel MA; Mahalingam R
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30404798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varicella-zoster virus infection: natural history, clinical manifestations, immunity and current and future vaccination strategies.
    Freer G; Pistello M
    New Microbiol; 2018 Apr; 41(2):95-105. PubMed ID: 29498740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Live attenuated varicella vaccine.
    Arvin AM; Gershon AA
    Annu Rev Microbiol; 1996; 50():59-100. PubMed ID: 8905076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simian varicella: a model for human varicella-zoster virus infections.
    Gray WL
    Rev Med Virol; 2004; 14(6):363-81. PubMed ID: 15386593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging drugs for varicella-zoster virus infections.
    Andrei G; Snoeck R
    Expert Opin Emerg Drugs; 2011 Sep; 16(3):507-35. PubMed ID: 21699441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the Whole-Genome Sequence of an Oka Varicella Vaccine from China with Other Oka Vaccine Strains Reveals Sites Putatively Critical for Vaccine Efficacy.
    Wu Q; Rivailler P; Xu S; Xu W
    J Virol; 2019 May; 93(9):. PubMed ID: 30728261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced Potency and Persistence of Immunity to Varicella-Zoster Virus Glycoprotein E in Mice by Addition of a Novel BC02 Compound Adjuvant.
    Li J; Fu L; Yang Y; Wang G; Zhao A
    Vaccines (Basel); 2022 Mar; 10(4):. PubMed ID: 35455278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current In Vivo Models of Varicella-Zoster Virus Neurotropism.
    Mahalingam R; Gershon A; Gershon M; Cohen JI; Arvin A; Zerboni L; Zhu H; Gray W; Messaoudi I; Traina-Dorge V
    Viruses; 2019 May; 11(6):. PubMed ID: 31159224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.